Edward Brennan
Presidente presso InClinica, Inc.
Patrimonio netto: 182 125 $ in data 31/05/2024
Profilo
Edward J.
Brennan is currently the Director at Skinject, Inc., the President & Chief Medical Officer at InClinica, Inc., and the Chief Medical Officer at Medicus Pharma Ltd.
Previously, he served as an Independent Director at Solarvest BioEnergy, Inc. in 2020.
He also held positions as a Medical Director at Wyeth-Ayerst Research and GlaxoSmithKline LLC.
Additionally, he served as the President-BioSciences Division at FSD Pharma, Inc. Dr. Brennan obtained a doctorate degree from Temple University School of Medicine and an undergraduate degree from Philadelphia College of Pharmacy.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
0.77% | 24/10/2023 | 125 000 ( 0.77% ) | 182 125 $ | 31/05/2024 |
Posizioni attive di Edward Brennan
| Società | Posizione | Inizio |
|---|---|---|
InClinica, Inc.
 InClinica, Inc. BiotechnologyHealth Technology InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA. | Presidente | - |
Skinject, Inc.
 Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | Direttore/Membro del Consiglio | 18/10/2023 |
Precedenti posizioni note di Edward Brennan
| Società | Posizione | Fine |
|---|---|---|
| SOLARVEST BIOENERGY INC. | Direttore/Membro del Consiglio | 25/11/2020 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Direttore Tecnico/Scientifico/R&S | - |
| Wyeth-Ayerst Research | Direttore Tecnico/Scientifico/R&S | - |
| FSD PHARMA INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Edward Brennan
| Temple University School of Medicine | Doctorate Degree |
| Philadelphia College of Pharmacy | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SOLARVEST BIOENERGY INC. | Utilities |
| FSD PHARMA INC. | Health Technology |
| Aziende private | 4 |
|---|---|
InClinica, Inc.
InClinica, Inc. BiotechnologyHealth Technology InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA. | Health Technology |
| Wyeth-Ayerst Research | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Skinject, Inc.
Skinject, Inc. Hospital/Nursing ManagementHealth Services Skinject, Inc. operates as a biotechnology company. It offers treatment for common forms of non melanoma skin cancer, basal cell, and squamous cell carcinoma. The company was founded by Louis D. Falo and is headquartered in Pittsburgh, PA. | Health Services |
- Borsa valori
- Insiders
- Edward Brennan
